HCM vs ZLAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

HCM

44.1
AI Score
VS
ZLAB Wins

ZLAB

47.4
AI Score

Investment Advisor Scores

HCM

44score
Recommendation
HOLD

ZLAB

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HCM ZLAB Winner
Revenue 52.17M 99.61M ZLAB
Net Income -19.89M -51.02M HCM
Net Margin -38.1% -51.2% HCM
Operating Income -36.05M -69.39M HCM
ROE -5.3% -7.7% HCM
ROA -3.7% -4.7% HCM
Total Assets 539.30M 1.10B ZLAB
Cash 91.69M 651.32M ZLAB
Current Ratio 3.45 2.40 HCM
Free Cash Flow -30.28M -13.11M ZLAB

Relative Price Performance (Last 90 Days)

HCM 1M: +1.0% · 3M: -13.1% ZLAB 1M: -4.4% · 3M: -15.2%

Current Technical Phase

HCM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 56.3 · Price: $11.56

ZLAB

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -2.1%) with fading momentum, RSI 40

RSI (14): 39.7 · Price: $18.27

Fundamentals Snapshot

Metric HCM ZLAB
Market Cap
Forward P/E 30.6 -10.4
Trailing P/E 4.3
Revenue (TTM)
Revenue Growth -0.2% -0.1%
Gross Margin 0.1% 0.1%
Operating Margin -0.1% -0.7%
EPS 2.52 -1.70
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ZLAB is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.